ExploreOutcomeGleason prostate grade 2-4 (low)
Outcome

Gleason prostate grade 2-4 (low)

Also known as: Gleason Score 2-4: Well differentiated Gleason Score 2-4: Well differentiated (finding) Gleason Score 2-4: Well differentiated (staging scale) Gleason prostate grade 2-4 (low) Gleason prostate grade 2-4 (low) (finding) Grade 2-4 pain and toxicities at all time points post-donation Grade 2-4 skeletal pain at 1 month post-donation
9 findings 1 paper 6 related entities View in graph →

Related entities

interventions
conditions
studys

Findings (50)

None
decline

Related PBSC donors with pre-donation PCS scores in the highest quartile were significantly less likely to report grade 2-4 pain at 1 month post-donation compared with donors with PCS scores in the lo

Effect: decline; OR 0.1; CI: 95% CI 0.01-0.83

Size: OR 0.1 CI: 95% CI 0.01-0.83
None
decline

Related PBSC donors with pre-donation PCS scores in the highest quartile were significantly less likely to report grade 2-4 pain at 1 month post-donation compared with donors with PCS scores in the lo

Effect: decline; OR 0.1; CI: 95% CI 0.01-0.83

Size: OR 0.1 CI: 95% CI 0.01-0.83
None
decline

Related PBSC donors with pre-donation PCS scores in the highest quartile were significantly less likely to report grade 2-4 pain at 1 month post-donation compared with donors with PCS scores in the lo

Effect: decline; OR 0.1; CI: 95% CI 0.01-0.83

Size: OR 0.1 CI: 95% CI 0.01-0.83
None
decline

Related PBSC donors with pre-donation PCS scores in the highest quartile were significantly less likely to report grade 2-4 pain at 1 month post-donation compared with donors with PCS scores in the lo

Effect: decline; OR 0.1; CI: 95% CI 0.01-0.83

Size: OR 0.1 CI: 95% CI 0.01-0.83
None
decline

Related PBSC donors with pre-donation PCS scores in the highest quartile were significantly less likely to report grade 2-4 pain at 1 month post-donation compared with donors with PCS scores in the lo

Effect: decline; OR 0.1; CI: 95% CI 0.01-0.83

Size: OR 0.1 CI: 95% CI 0.01-0.83
None
decline

Related PBSC donors with pre-donation PCS scores in the highest quartile were significantly less likely to report grade 2-4 pain at 1 month post-donation compared with donors with PCS scores in the lo

Effect: decline; OR 0.1; CI: 95% CI 0.01-0.83

Size: OR 0.1 CI: 95% CI 0.01-0.83
None
decline

Related PBSC donors with pre-donation PCS scores in the highest quartile were significantly less likely to report grade 2-4 pain at 1 month post-donation compared with donors with PCS scores in the lo

Effect: decline; OR 0.1; CI: 95% CI 0.01-0.83

Size: OR 0.1 CI: 95% CI 0.01-0.83
None
decline

Related PBSC donors with pre-donation PCS scores in the highest quartile were significantly less likely to report grade 2-4 pain at 1 month post-donation compared with donors with PCS scores in the lo

Effect: decline; OR 0.1; CI: 95% CI 0.01-0.83

Size: OR 0.1 CI: 95% CI 0.01-0.83
None
decline

Related PBSC donors with pre-donation PCS scores in the highest quartile were significantly less likely to report grade 2-4 pain at 1 month post-donation compared with donors with PCS scores in the lo

Effect: decline; OR 0.1; CI: 95% CI 0.01-0.83

Size: OR 0.1 CI: 95% CI 0.01-0.83
None
decline

Related PBSC donors with pre-donation PCS scores in the highest quartile were significantly less likely to report grade 2-4 pain at 1 month post-donation compared with donors with PCS scores in the lo

Effect: decline; OR 0.1; CI: 95% CI 0.01-0.83

Size: OR 0.1 CI: 95% CI 0.01-0.83
None
decline

Related PBSC donors with pre-donation PCS scores in the highest quartile were significantly less likely to report grade 2-4 pain at 1 month post-donation compared with donors with PCS scores in the lo

Effect: decline; OR 0.1; CI: 95% CI 0.01-0.83

Size: OR 0.1 CI: 95% CI 0.01-0.83
None
decline

Related PBSC donors with pre-donation PCS scores in the highest quartile were significantly less likely to report grade 2-4 pain at 1 month post-donation compared with donors with PCS scores in the lo

Effect: decline; OR 0.1; CI: 95% CI 0.01-0.83

Size: OR 0.1 CI: 95% CI 0.01-0.83
None
decline

Related PBSC donors with pre-donation PCS scores in the highest quartile were significantly less likely to report grade 2-4 pain at 1 month post-donation compared with donors with PCS scores in the lo

Effect: decline; OR 0.1; CI: 95% CI 0.01-0.83

Size: OR 0.1 CI: 95% CI 0.01-0.83
None
decline

Related PBSC donors with pre-donation PCS scores in the highest quartile were significantly less likely to report grade 2-4 pain at 1 month post-donation compared with donors with PCS scores in the lo

Effect: decline; OR 0.1; CI: 95% CI 0.01-0.83

Size: OR 0.1 CI: 95% CI 0.01-0.83
None
decline

Related PBSC donors with pre-donation PCS scores in the highest quartile were significantly less likely to report grade 2-4 pain at 1 month post-donation compared with donors with PCS scores in the lo

Effect: decline; OR 0.1; CI: 95% CI 0.01-0.83

Size: OR 0.1 CI: 95% CI 0.01-0.83
None
decline

Related PBSC donors with pre-donation PCS scores in the highest quartile were significantly less likely to report grade 2-4 pain at 1 month post-donation compared with donors with PCS scores in the lo

Effect: decline; OR 0.1; CI: 95% CI 0.01-0.83

Size: OR 0.1 CI: 95% CI 0.01-0.83
None
decline

Related PBSC donors with pre-donation PCS scores in the highest quartile were significantly less likely to report grade 2-4 pain at 1 month post-donation compared with donors with PCS scores in the lo

Effect: decline; OR 0.1; CI: 95% CI 0.01-0.83

Size: OR 0.1 CI: 95% CI 0.01-0.83
None
decline

Related PBSC donors with pre-donation PCS scores in the highest quartile were significantly less likely to report grade 2-4 pain at 1 month post-donation compared with donors with PCS scores in the lo

Effect: decline; OR 0.1; CI: 95% CI 0.01-0.83

Size: OR 0.1 CI: 95% CI 0.01-0.83
None
decline

Related PBSC donors with pre-donation PCS scores in the highest quartile were significantly less likely to report grade 2-4 pain at 1 month post-donation compared with donors with PCS scores in the lo

Effect: decline; OR 0.1; CI: 95% CI 0.01-0.83

Size: OR 0.1 CI: 95% CI 0.01-0.83
None
decline

Related PBSC donors with pre-donation PCS scores in the highest quartile were significantly less likely to report grade 2-4 pain at 1 month post-donation compared with donors with PCS scores in the lo

Effect: decline; OR 0.1; CI: 95% CI 0.01-0.83

Size: OR 0.1 CI: 95% CI 0.01-0.83
None
decline

Related PBSC donors with pre-donation PCS scores in the highest quartile were significantly less likely to report grade 2-4 pain at 1 month post-donation compared with donors with PCS scores in the lo

Effect: decline; OR 0.1; CI: 95% CI 0.01-0.83

Size: OR 0.1 CI: 95% CI 0.01-0.83
None
decline

Related PBSC donors with pre-donation PCS scores in the highest quartile were significantly less likely to report grade 2-4 pain at 1 month post-donation compared with donors with PCS scores in the lo

Effect: decline; OR 0.1; CI: 95% CI 0.01-0.83

Size: OR 0.1 CI: 95% CI 0.01-0.83
None
decline

Related PBSC donors with pre-donation PCS scores in the highest quartile were significantly less likely to report grade 2-4 pain at 1 month post-donation compared with donors with PCS scores in the lo

Effect: decline; OR 0.1; CI: 95% CI 0.01-0.83

Size: OR 0.1 CI: 95% CI 0.01-0.83
None
decline

Related PBSC donors with pre-donation PCS scores in the highest quartile were significantly less likely to report grade 2-4 pain at 1 month post-donation compared with donors with PCS scores in the lo

Effect: decline; OR 0.1; CI: 95% CI 0.01-0.83

Size: OR 0.1 CI: 95% CI 0.01-0.83
None
decline

Related PBSC donors with pre-donation PCS scores in the highest quartile were significantly less likely to report grade 2-4 pain at 1 month post-donation compared with donors with PCS scores in the lo

Effect: decline; OR 0.1; CI: 95% CI 0.01-0.83

Size: OR 0.1 CI: 95% CI 0.01-0.83
None
decline

Related PBSC donors with pre-donation PCS scores in the highest quartile were significantly less likely to report grade 2-4 pain at 1 month post-donation compared with donors with PCS scores in the lo

Effect: decline; OR 0.1; CI: 95% CI 0.01-0.83

Size: OR 0.1 CI: 95% CI 0.01-0.83
None
decline

Related PBSC donors with pre-donation PCS scores in the highest quartile were significantly less likely to report grade 2-4 pain at 1 month post-donation compared with donors with PCS scores in the lo

Effect: decline; OR 0.1; CI: 95% CI 0.01-0.83

Size: OR 0.1 CI: 95% CI 0.01-0.83
None
null

Pre-donation mental health status (MCS score), depression, and anxiety levels were not significantly associated with donation-associated pain and toxicities at any time point post-donation in related

Effect: null

None
null

Pre-donation mental health status (MCS score), depression, and anxiety levels were not significantly associated with donation-associated pain and toxicities at any time point post-donation in related

Effect: null

None
null

Pre-donation mental health status (MCS score), depression, and anxiety levels were not significantly associated with donation-associated pain and toxicities at any time point post-donation in related

Effect: null

None
null

Neither pre-donation physical nor mental component summary scores were associated with post-donation grade 2-4 pain or toxicities at any time point in unrelated PBSC donors.

Effect: null

None
null

Neither pre-donation physical nor mental component summary scores were associated with post-donation grade 2-4 pain or toxicities at any time point in unrelated PBSC donors.

Effect: null

None
null

Neither pre-donation physical nor mental component summary scores were associated with post-donation grade 2-4 pain or toxicities at any time point in unrelated PBSC donors.

Effect: null

None
null

Neither pre-donation physical nor mental component summary scores were associated with post-donation grade 2-4 pain or toxicities at any time point in unrelated PBSC donors.

Effect: null

None
null

Neither pre-donation physical nor mental component summary scores were associated with post-donation grade 2-4 pain or toxicities at any time point in unrelated PBSC donors.

Effect: null

None
null

Neither pre-donation physical nor mental component summary scores were associated with post-donation grade 2-4 pain or toxicities at any time point in unrelated PBSC donors.

Effect: null

None
null

Neither pre-donation physical nor mental component summary scores were associated with post-donation grade 2-4 pain or toxicities at any time point in unrelated PBSC donors.

Effect: null

None
null

Neither pre-donation physical nor mental component summary scores were associated with post-donation grade 2-4 pain or toxicities at any time point in unrelated PBSC donors.

Effect: null

None
null

Neither pre-donation physical nor mental component summary scores were associated with post-donation grade 2-4 pain or toxicities at any time point in unrelated PBSC donors.

Effect: null

None
null

Neither pre-donation physical nor mental component summary scores were associated with post-donation grade 2-4 pain or toxicities at any time point in unrelated PBSC donors.

Effect: null

None
null

Neither pre-donation physical nor mental component summary scores were associated with post-donation grade 2-4 pain or toxicities at any time point in unrelated PBSC donors.

Effect: null

None
null

Neither pre-donation physical nor mental component summary scores were associated with post-donation grade 2-4 pain or toxicities at any time point in unrelated PBSC donors.

Effect: null

None
null

Neither pre-donation physical nor mental component summary scores were associated with post-donation grade 2-4 pain or toxicities at any time point in unrelated PBSC donors.

Effect: null

None
null

Neither pre-donation physical nor mental component summary scores were associated with post-donation grade 2-4 pain or toxicities at any time point in unrelated PBSC donors.

Effect: null

None
null

Neither pre-donation physical nor mental component summary scores were associated with post-donation grade 2-4 pain or toxicities at any time point in unrelated PBSC donors.

Effect: null

None
null

Neither pre-donation physical nor mental component summary scores were associated with post-donation grade 2-4 pain or toxicities at any time point in unrelated PBSC donors.

Effect: null

None
null

Neither pre-donation physical nor mental component summary scores were associated with post-donation grade 2-4 pain or toxicities at any time point in unrelated PBSC donors.

Effect: null

None
null

Neither pre-donation physical nor mental component summary scores were associated with post-donation grade 2-4 pain or toxicities at any time point in unrelated PBSC donors.

Effect: null

None
null

Neither pre-donation physical nor mental component summary scores were associated with post-donation grade 2-4 pain or toxicities at any time point in unrelated PBSC donors.

Effect: null

None
null

Neither pre-donation physical nor mental component summary scores were associated with post-donation grade 2-4 pain or toxicities at any time point in unrelated PBSC donors.

Effect: null

Papers (1)